About: Immunogenicity and safety of an investigational quadrivalent meningococcal ACWY tetanus toxoid conjugate vaccine in healthy adolescents and young adults 10 to 25 years of age

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Immunogenicity and safety of an investigational quadrivalent meningococcal ACWY tetanus toxoid conjugate vaccine in healthy adolescents and young adults 10 to 25 years of age Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 March 2011

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) bài báo khoa học (vi) наукова стаття, опублікована в березні 2011 (uk) article scientifique publié en 2011 (fr) im März 2011 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en marzu de 2011 (ast) scientific article published on 01 March 2011 (en)
publication date	wds:Q83106446-2EB075EA-0CF1-4320-B02D-29DB5EB2ECA7
publication date	2011-03-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q83106446-6D3C4D69-6C44-472D-BFFD-71D4F2857002 wds:Q83106446-77F96187-6267-4726-ACBC-D1EA20DF5FC3 wds:Q83106446-7D20901F-2A72-42A3-9DFA-323B45C95A2F wds:Q83106446-828EF325-19A0-48CB-9CF1-5E1BB47ED9B3 wds:Q83106446-88D50870-F0F9-4450-B74E-417FBFD49853
author name string	Jacqueline M Miller Veronique Bianco Yaela Baine Leonard R Friedland Kathleen Ensor
rdfs:label	Immunogenicity and safety of an investigational quadrivalent meningococcal ACWY tetanus toxoid conjugate vaccine in healthy adolescents and young adults 10 to 25 years of age (en) Immunogenicity and safety of an investigational quadrivalent meningococcal ACWY tetanus toxoid conjugate vaccine in healthy adolescents and young adults 10 to 25 years of age (nl)
skos:prefLabel	Immunogenicity and safety of an investigational quadrivalent meningococcal ACWY tetanus toxoid conjugate vaccine in healthy adolescents and young adults 10 to 25 years of age (en) Immunogenicity and safety of an investigational quadrivalent meningococcal ACWY tetanus toxoid conjugate vaccine in healthy adolescents and young adults 10 to 25 years of age (nl)
name	Immunogenicity and safety of an investigational quadrivalent meningococcal ACWY tetanus toxoid conjugate vaccine in healthy adolescents and young adults 10 to 25 years of age (en) Immunogenicity and safety of an investigational quadrivalent meningococcal ACWY tetanus toxoid conjugate vaccine in healthy adolescents and young adults 10 to 25 years of age (nl)
author	wds:Q83106446-793F07EE-8134-42A3-A40A-5C4EA4B7D424
author	Roger Baxter
title	wds:Q83106446-D313DEA3-39D3-4D50-B0D5-DFE9BE0EEC61
title	Immunogenicity and safety of an investigational quadrivalent meningococcal ACWY tetanus toxoid conjugate vaccine in healthy adolescents and young adults 10 to 25 years of age (en)
page(s)	wds:Q83106446-8C1B9832-ED3D-487E-BE6B-696F075B7DA4
page(s)	e41-8
instance of	wds:Q83106446-47AAB56F-2C11-40DC-85F6-957D78677B16
instance of	scholarly article
main subject	wds:Q83106446-04FF4986-5387-4B98-B5D7-C8108414CCEA
main subject	tetanus vaccine
PubMed ID	wds:Q83106446-DFA63B0D-7938-485D-A714-CB927483FB41
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21200360
PubMed ID	21200360
published in	wds:Q83106446-FB15285D-33C3-4F21-9D5D-18D46F7759C8
published in	Pediatric Infectious Disease Journal
issue	wds:Q83106446-3392CA6B-7957-433A-888C-A52C610551C7
volume	wds:Q83106446-28E15A16-9026-4208-B698-C7916C3211DE
issue	3
volume	30
DOI	wds:Q83106446-247D614F-E97E-43EA-A7EF-D6C2CB8FA0B9
DOI	http://dx.doi.org/10.1097/INF.0B013E3182054AB9
DOI	10.1097/INF.0B013E3182054AB9
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q83106446
is cites work of	Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study Immune response, antibody persistence, and safety of a single dose of the quadrivalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine in adolescents and adults: results of an open, randomised, controlled study Conjugate Meningococcal Vaccines Development: GSK Biologicals Experience Protein carriers of conjugate vaccines: characteristics, development, and clinical trials Antibody persistence and immune memory 15 months after priming with an investigational tetravalent meningococcal tetanus toxoid conjugate vaccine (MenACWY-TT) in toddlers and young children Persistence of the immune response two years after vaccination with quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in Asian adolescents Antibody persistence up to 5 y after vaccination with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine in adolescents Serum bactericidal antibody assays - The role of complement in infection and immunity Routinely vaccinating adolescents against meningococcus: targeting transmission & disease Long-term immunogenicity and safety after a single dose of the quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine in adolescents and adults: 5-year follow-up of an open, randomized trial Immunogenicity and safety of a quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) administered to adults aged 56 Years and older: results of an open-label, randomized, controlled trial A randomized study to assess the immunogenicity, antibody persistence and safety of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in children aged 2-10 years Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease Meningococcal quadrivalent (serogroups A, C, W135 and Y) tetanus toxoid conjugate vaccine (Nimenrix™). A tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when co-administered with Twinrix® in subjects aged 11–17 years: An open, randomised, controlled trial Meningococcal Quadrivalent Tetanus Toxoid Conjugate Vaccine (MenACWY-TT; Nimenrix®): A Review. Immunogenicity and reactogenicity of Infanrix™ when co-administered with meningococcal MenACWY-TT conjugate vaccine in toddlers primed with MenHibrix™ and Pediarix™. The immunogenicity and safety of an investigational meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate vaccine (ACWY-TT) compared with a licensed meningococcal tetravalent polysaccharide vaccine: a randomized, controlled non-inferiorit The investigational meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate vaccine (ACWY-TT) and the seasonal influenza virus vaccine are immunogenic and well-tolerated when co-administered in adults Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers Meningococcal quadrivalent tetanus toxoid conjugate vaccine (MenACWY-TT, Nimenrix™): A review of its immunogenicity, safety, co-administration, and antibody persistence Meningococcal polysaccharide A O-acetylation levels do not impact the immunogenicity of the quadrivalent meningococcal tetanus toxoid conjugate vaccine: results from a randomized, controlled phase III study of healthy adults aged 18 to 25 years Comparison of the Safety and Immunogenicity of a Novel Quadrivalent Meningococcal ACWY-Tetanus Toxoid Conjugate Vaccine and a Marketed Quadrivalent Meningococcal ACWY-Diphtheria Toxoid Conjugate Vaccine in Healthy Individuals 10-25 Years of Age. Cost-effectiveness of meningococcal polysaccharide serogroups A, C, W-135 and Y conjugate vaccine in Australian adolescents Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in ≥56-year-olds: A Phase III randomized study Immunogenicity, safety and inter-lot consistency of a meningococcal conjugate vaccine (MenACYW-TT) in adolescents and adults: A Phase III randomized study A review of complement sources used in serum bactericidal assays for evaluating immune responses to meningococcal ACWY conjugate vaccines Quadrivalent meningococcal (MenACWY-TT) conjugate vaccine or a fourth dose of H. influenzae-N. meningitidis C/Y conjugate vaccine (HibMenCY-TT) is immunogenic in toddlers who previously received three doses of HibMenCY-TT in infancy Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescents Kaiser Permanente Vaccine Study Center: Highlights of 2009-2012. Immunogenicity and safety of the quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in splenectomized or hyposplenic children and adolescents: Results of a phase III, open, non-randomized study.
is cites work of	wds:Q34627685-A38E6FBF-0190-4A4B-8160-620A01BFDA66 wds:Q37713775-DAEF158B-D878-4261-B8CC-87E044209346 wds:Q60469224-D22A8E0A-4F5B-4590-83FB-70E850B7922C wds:Q47672096-97F43C28-0A5E-472C-9381-4080FAC6C589 wds:Q91851247-CA11745D-E1D5-46DC-8B1E-C2B24F05775A wds:Q96603926-6862DFCD-3B3F-4FEA-B377-0B055E0284B9 wds:Q36391874-A5091FBB-FDD6-4804-A37F-724993164E43 wds:Q36391888-F7BAA7AA-2CFC-48AC-8036-BA3B6E044F9A wds:Q35799561-D741BB4E-E62B-46BC-98C2-73A7C85765DE wds:Q37197065-A966FBDB-F42D-46C1-A7AF-E6DEFC4DADC4 wds:Q38743826-90BBA638-35B5-4B6C-AF5A-AD5F1188B53B wds:Q37600163-B7CED407-4BEC-469D-A70A-D3781831631B wds:Q94587781-15A09E25-E407-4CAE-A383-851399D0DF37 wds:Q37252405-48EDF7AB-74E9-42B4-B4E5-D1D0A57E64C2 wds:Q36825737-AFBF6497-54ED-473F-80E3-7D0F42C0974D wds:Q36391883-B4066104-9322-451B-BF41-B9B2DBBE21E1 wds:Q87648371-FDA1DAE7-0602-4BF9-8DD4-2E81C0042818 wds:Q34170021-B12D8D0A-1E9D-483F-9B3B-67B499933EF5 wds:Q38549601-78116E88-2E8D-4822-B676-29D08422C67D wds:Q36791713-592D580F-9EF7-4B97-AE42-6210494D6B51

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software